| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020616A1 Hla-a2.1 binding peptides and their uses |
| 03/14/2002 | WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | WO2002020565A2 Collections of repeat proteins comprising repeat modules |
| 03/14/2002 | WO2002020561A1 Novel polypeptides and anti-hiv drugs containing the same |
| 03/14/2002 | WO2002020555A2 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 03/14/2002 | WO2002020554A2 Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines |
| 03/14/2002 | WO2002020538A2 Stavudine polymorphic form 1 process |
| 03/14/2002 | WO2002020532A1 Intermediates in cephalosporin production |
| 03/14/2002 | WO2002020527A1 Soluble compounds for the inhibition of multidrug resistance and pharmaceutical compositions thereof |
| 03/14/2002 | WO2002020515A1 Oxazolidinone antibacterial agents |
| 03/14/2002 | WO2002020514A1 Multivalent neuraminidase inhibitor conjugates |
| 03/14/2002 | WO2002020497A1 Compounds having anti-hepatitis c virus effect |
| 03/14/2002 | WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | WO2002020484A1 Chemical compounds |
| 03/14/2002 | WO2002020483A1 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | WO2002020057A2 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
| 03/14/2002 | WO2002020054A2 Methods of treatment and diagnosis of hcv infection in cns based on magnetic resonance spectroscopy |
| 03/14/2002 | WO2002020053A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002020051A2 Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments |
| 03/14/2002 | WO2002020050A2 Eiav p26 deletion vaccine and diagnostic |
| 03/14/2002 | WO2002020049A2 Eiav chimeric vaccine and diagnostic |
| 03/14/2002 | WO2002020048A1 A classical swine fever virus epitope vaccine and its producing method |
| 03/14/2002 | WO2002020046A1 Multicomponent mscramm vaccine |
| 03/14/2002 | WO2002020045A2 Vaccine against microbial pathogens |
| 03/14/2002 | WO2002020043A1 Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator |
| 03/14/2002 | WO2002020041A2 Eia vaccine and diagnostic |
| 03/14/2002 | WO2002020035A1 Hla binding peptides and their uses |
| 03/14/2002 | WO2002020034A1 'pseudo'-native chemical ligation |
| 03/14/2002 | WO2002020033A1 Polymer-modified synthetic proteins |
| 03/14/2002 | WO2002020026A2 Treatment of drug resistant organisms with nitric oxide |
| 03/14/2002 | WO2002020014A1 Incompetitive inhibitors of helicase primase |
| 03/14/2002 | WO2002019994A2 The treatment of inflammatory disorders |
| 03/14/2002 | WO2002019986A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | WO2002019963A2 Synthetic erythropoiesis stimulating proteins |
| 03/14/2002 | WO2002004405A3 13-substituted methacycline compounds |
| 03/14/2002 | WO2001078655A3 Methods and compositions for heat shock protein mediated immunotherapy of melanoma |
| 03/14/2002 | WO2001077358A3 Herpes viruses for immune modulation |
| 03/14/2002 | WO2001074790A3 Novel compounds for enhancing chemotherapy |
| 03/14/2002 | WO2001072290A3 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 03/14/2002 | WO2001070768A3 Receptor-binding compounds and method for identifying them |
| 03/14/2002 | WO2001070734A3 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 03/14/2002 | WO2001070692A3 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 03/14/2002 | WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 03/14/2002 | WO2001070668B1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 03/14/2002 | WO2001070173A3 Immunokine composition and method |
| 03/14/2002 | WO2001068129A3 Adjuvant for vaccines |
| 03/14/2002 | WO2001066138A3 Dna vaccines against poxviruses |
| 03/14/2002 | WO2001063278A3 Antigenic fragments associated with stress-induced proteins and their use as vaccines |
| 03/14/2002 | WO2001060801A3 9-alkylamino-1-nitroacridine derivatives |
| 03/14/2002 | WO2001059129A3 Mammalian secreted group iii phospholipase a2 |
| 03/14/2002 | WO2001059126A3 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 03/14/2002 | WO2001057085A3 G-protein coupled receptors |
| 03/14/2002 | WO2001047551A3 Eliciting antibodies specific for hepatitis c virus (hcv) |
| 03/14/2002 | WO2001040472A3 Streptococcus pneumoniae antigens |
| 03/14/2002 | WO2001038302A3 Coupling condensation synthesis of heterocycles |
| 03/14/2002 | WO2001035993A3 Compositions and methods for stimulating an immune response against infectious agents |
| 03/14/2002 | WO2001032130A3 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 03/14/2002 | WO2001030327A3 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of ischaemic conditions |
| 03/14/2002 | WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 03/14/2002 | WO2001023572A3 Polynucleotides and polypeptides encoded thereby |
| 03/14/2002 | WO2001021651A3 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/14/2002 | WO2001002018A3 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 03/14/2002 | WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 03/14/2002 | WO2000053742A9 Polynucleotides and proteins encoded thereby |
| 03/14/2002 | WO1997003998A9 Modulators of the function of fas receptors and other proteins |
| 03/14/2002 | US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals |
| 03/14/2002 | US20020032328 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides |
| 03/14/2002 | US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media |
| 03/14/2002 | US20020032307 Hepadnavirus pre-S protein fragments |
| 03/14/2002 | US20020032306 Cyclopeptide derivatives |
| 03/14/2002 | US20020032229 Novel compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 03/14/2002 | US20020032228 Inhibiting adenylate cyclase with a composition comprising an amount of a heterocycle-containing compound (e.g., imidazole, Celebrex or DuP-697) effective to inhibit the generation of cAMP from ATP |
| 03/14/2002 | US20020032224 Treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system disorders |
| 03/14/2002 | US20020032221 Treatment of HIV mediated diseases. |
| 03/14/2002 | US20020032204 Reacting a substituted indol-2-one compound with an acyclic or cyclic amine free of piperidine-1-yl or morpholine-4-yl to form protein kinase inhibitor |
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | US20020032170 Underivatized, aqueous soluble beta (1-3) glucan, composition and method of making same |
| 03/14/2002 | US20020032165 Microspheres and adjuvants for DNA vaccine delivery |
| 03/14/2002 | US20020032164 For sanitizing surfaces |
| 03/14/2002 | US20020032162 For inducing immune responses in a vertebrate against Mycobacterial epitopes |
| 03/14/2002 | US20020032152 Anti-helicobacter vaccine complex |
| 03/14/2002 | US20020031823 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene |
| 03/14/2002 | US20020031819 Screening process for antibacterial agents |
| 03/14/2002 | US20020031537 Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and textile fibre materials |
| 03/14/2002 | US20020031530 In ovo vaccination against coccidiosis |
| 03/14/2002 | US20020031528 Vaccines containing beta-hexosamine bind with antibodies and carriers |
| 03/14/2002 | US20020031526 Reacting with a base to form a de-n-acetylated product, and depolymerizing with a nitrosation agent |
| 03/14/2002 | US20020031524 Polysaccharide and complexes contain glucose and any of galactose, rhamnose, mannose, arabinose, n-acetyl glucosamine and n-acetyl galactosamine; increase proliferation of splenocytes and cytokine production; immunomodulators |
| 03/14/2002 | US20020031511 Chemically-modified group B polysaccharides of Neisseria meningitidis for use as vaccines |
| 03/14/2002 | US20020031507 Treatment of inflammatory processes of the intestine, hypercholesterolaemia and infections with Helicobacter pylori; anticarcinogenic agent |
| 03/14/2002 | DE10128266A1 Verfahren zur Herstellung eines Extrakts mit starker Antiinflammations-Antiblutplättchenaggregations- und Antifungi-Aktivität aus Zingiber officinale und pharmazeutische Zusammensetzungen, die diesen Extrakt enthalten A process for preparing an extract with a strong Antiinflammations-Antiblutplättchenaggregations- and antifungal activity of Zingiber officinale and pharmaceutical compositions containing this extract |
| 03/14/2002 | DE10043667A1 2-Guanidino-4-aryl-chinazoline 2-guanidino-4-aryl-quinazolines |
| 03/14/2002 | DE10041402A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity |
| 03/14/2002 | CA2422506A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice |
| 03/14/2002 | CA2421922A1 Proteases |
| 03/14/2002 | CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |